Author | Neil P. Shah, MD, PhD | OncLive

Author | Neil P. Shah, MD, PhD


Dr. Shah on TKI Treatment Discontinuation in CML

April 24, 2019


Neil P. Shah, MD, PhD, professor of medicine, Division of Hematology and Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses TKI treatment discontinuation in patients with chronic myeloid leukemia.